{
  "title": "LAI Weekly Intelligence â€“ 2025-12-12",
  "intro": "Newsletter generated in fallback mode (Bedrock error).",
  "tldr": [],
  "sections": [
    {
      "section_title": "LAI Technology & Innovation",
      "section_intro": "",
      "items": [
        {
          "title": "Nanexa and Moderna Announce PharmaShell Technology Partnership",
          "rewritten_summary": "Nanexa AB announces strategic partnership with Moderna to develop PharmaShell technology for extended-release injectable formulations.",
          "url": "https://nanexa.com/press-release-moderna-partnership"
        },
        {
          "title": "UZEDY (aripiprazole) Extended-Release Injectable Shows Positive Phase 3 Results",
          "rewritten_summary": "Teva Pharmaceutical announces positive Phase 3 clinical trial results for UZEDY, a novel extended-release injectable formulation.",
          "url": "https://tevapharm.com/uzedy-phase3-results"
        }
      ]
    },
    {
      "section_title": "Funding & Business Development",
      "section_intro": "",
      "items": [
        {
          "title": "Nanexa and Moderna Announce PharmaShell Technology Partnership",
          "rewritten_summary": "Nanexa AB announces strategic partnership with Moderna to develop PharmaShell technology for extended-release injectable formulations.",
          "url": "https://nanexa.com/press-release-moderna-partnership"
        },
        {
          "title": "MedinCell Receives 2.5M Grant for Malaria Prevention LAI Development",
          "rewritten_summary": "MedinCell secures 2.5 million grant to advance development of long-acting injectable malaria prevention treatment using BEPO technology.",
          "url": "https://medincell.com/malaria-grant-announcement"
        }
      ]
    }
  ]
}